Navigation follows, skip to content? New England Baptist Hospital Logo Utility navigation follows, skip to content? Primary navigation follows, skip to content?

Need help finding a doc?

Request a Call Back | Chat Now | Call the Physician Referral Line: 1-855-370-NEBH (6324)

Mark Paul Slovenkai, MD

Chief, Foot & Ankle Surgery

Boston Bone & Joint Institute-Waltham
Phone: 781-890-2133

840 Winter Street
Waltham, MA 02451
Fax: 781-890-2177

Please note: by clicking the above links you may be leaving the NEBH website.

Dr. Mark P. Slovenkai is Chief of Foot and Ankle Surgery at New England Baptist Hospital (NEBH). In addition to his work at NEBH, Dr. Slovenkai is an active faculty member of the American Orthopedic Foot and Ankle Society. He holds an academic appointment as Associate Clinical Professor of Orthopedic Surgery at Tufts School of Medicine, and consults for the Boston Celtics.

After earning his medical degree from Albany Medical College, Dr. Slovenkai completed his combined orthopedic residency at University of Massachusetts and his subspecialty training in foot and ankle at Medical College of Wisconsin.

Dr. Slovenkai’s clinical interests focus on sports medicine and reconstructive surgery of the foot and ankle.

Academic Affiliations

Associate Clinical Instructor: Tufts University School of Medicine, Orthopedic Surgery

Board Certification

American Board of Orthopedic Surgery

Medical Education

Medical School

Albany Medical College, 1984


UMass Memorial Medical Center, 1985


UMass Memorial Medical Center, 1989


Medical College of Wisconsin, 1993


Ankle Replacement, Orthopedic Surgery, Sports Medicine


Foot & Ankle

Footer navigation follows, return to top?

Our Cookie Policy

Your privacy is important to us. We use cookies and other tracking technologies to ensure the performance and security of our website and to monitor website use for business and website optimization purposes. This may include disclosures about your use of the website to third parties. By using our website, you agree to its use of these technologies. To learn more, please read our Terms of Use.